| 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ... The Lancet Oncology 20 (10), e566-e581, 2019 | 444 | 2019 |
| A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts I Pabinger, N van Es, G Heinze, F Posch, J Riedl, EM Reitter, M Di Nisio, ... The Lancet Haematology 5 (7), e289-e298, 2018 | 284 | 2018 |
| Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants F Posch, O Königsbrügge, C Zielinski, I Pabinger, C Ay Thrombosis research 136 (3), 582-589, 2015 | 244 | 2015 |
| Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients LM Mauracher, F Posch, K Martinod, E Grilz, T Däullary, L Hell, C Brostjan, ... Journal of Thrombosis and Haemostasis 16 (3), 508-518, 2018 | 222 | 2018 |
| Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer F Posch, K Silina, S Leibl, A Mündlein, H Moch, A Siebenhüner, ... Oncoimmunology 7 (2), e1378844, 2018 | 220 | 2018 |
| Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism J Riedl, M Preusser, PMS Nazari, F Posch, S Panzer, C Marosi, P Birner, ... Blood, The Journal of the American Society of Hematology 129 (13), 1831-1839, 2017 | 201 | 2017 |
| 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19 D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ... The Lancet Oncology 23 (7), e334-e347, 2022 | 174 | 2022 |
| Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer E Grilz, O Königsbrügge, F Posch, M Schmidinger, R Pirker, IM Lang, ... Haematologica 103 (9), 1549, 2018 | 116 | 2018 |
| Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality J Riedl, F Posch, O Königsbrügge, F Lötsch, EM Reitter, E Eigenbauer, ... PloS one 9 (10), e111440, 2014 | 96 | 2014 |
| Single-stage revision for the infected total knee replacement: results from a single centre S Tibrewal, F Malagelada, L Jeyaseelan, F Posch, G Scott The Bone & Joint Journal 96 (6), 759-764, 2014 | 89 | 2014 |
| Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer E Grilz, LM Mauracher, F Posch, O Königsbrügge, S Zöchbauer‐Müller, ... British journal of haematology 186 (2), 311-320, 2019 | 88 | 2019 |
| Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized … F Moik, F Posch, C Zielinski, I Pabinger, C Ay Research and practice in thrombosis and haemostasis 4 (4), 550-561, 2020 | 83 | 2020 |
| Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer—a nationwide analysis E Grilz, F Posch, S Nopp, O Königsbrügge, IM Lang, P Klimek, S Thurner, ... European heart journal 42 (23), 2299-2307, 2021 | 82 | 2021 |
| Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortality C Ay, F Posch, A Kaider, C Zielinski, I Pabinger Journal of Thrombosis and Haemostasis 13 (3), 390-397, 2015 | 80 | 2015 |
| Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients O Königsbrügge, F Posch, J Riedl, EM Reitter, C Zielinski, I Pabinger, ... The oncologist 21 (2), 252-257, 2016 | 79 | 2016 |
| Trends and economic impact of hip and knee arthroplasty in Central Europe: findings from the Austrian National Database L Leitner, S Türk, M Heidinger, B Stöckl, F Posch, W Maurer-Ertl, ... Scientific reports 8 (1), 4707, 2018 | 75 | 2018 |
| The prognostic impact of unplanned excisions in a cohort of 728 soft tissue sarcoma patients: a multicentre study MA Smolle, PU Tunn, E Goldenitsch, F Posch, J Szkandera, M Bergovec, ... Annals of surgical oncology 24, 1596-1605, 2017 | 74 | 2017 |
| Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study S Hatzl, AC Reisinger, F Posch, J Prattes, M Stradner, S Pilz, P Eller, ... Critical Care 25, 1-11, 2021 | 73 | 2021 |
| Hypercoagulabilty, venous thromboembolism, and death in patients with cancer F Posch, J Riedl, EM Reitter, A Kaider, C Zielinski, I Pabinger, C Ay Thrombosis and haemostasis 115 (04), 817-826, 2016 | 73 | 2016 |
| Increased mortality in patients with the lupus anticoagulant: the Vienna Lupus Anticoagulant and Thrombosis Study (LATS) J Gebhart, F Posch, S Koder, T Perkmann, P Quehenberger, C Zoghlami, ... Blood, The Journal of the American Society of Hematology 125 (22), 3477-3483, 2015 | 73 | 2015 |
Cihan AyProfessor, Medical University of Vienna, AustriaVerified email at meduniwien.ac.at
